Exercise and glycemic control in diabetes: Benefits, challenges, and adjustments to pharmacotherapy

Physical Therapy

Volumn 88, Issue 11, 2008, Pages 1297-1321

  Gulve, Eric Arthur ^a  

^a BioCenerator   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; CHLORPROPAMIDE; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; LIRAGLUTIDE; METFORMIN; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; PRAMLINTIDE; REPAGLINIDE; ROSIGLITAZONE; SITAGLIPTIN; VILDAGLIPTIN;

AEROBIC EXERCISE; CONGESTIVE HEART FAILURE; DIARRHEA; FLATULENCE; FLUID RETENTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LACTIC ACIDOSIS; MUSCLE CRAMP; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SIDE EFFECT; VOMITING; WEIGHT GAIN;

BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC DIET; EXERCISE; GLUCOSE; GLYCEMIC INDEX; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 55849118716     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.2522/ptj.20080114     Document Type: Review

References (89)

1. Hirsch IB. Insulin analogues. N Engl J Med. 2005;352:174-183.
2. Bolli GB. Insulin treatment in type 1 diabetes. Endocrine Practice. 2006;12(suppl 1):105-109.
3. Heine RJ, Diamant M, Mbanya J-C, et al. Management of hyperglycemia in type 2 diabetes. Br Med J. 2006;333:1200-1204.
4. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65:385-411.
5. Modi P. Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus. Curr Drug Discov Technol. 2007;4:39-47.
6. DeFronzo RA. The triumvirate: β-cell, muscle, liver - a collusion responsible for NIDDM. Diabetes. 1988;37:667-687.
7. American Diabetes Association. Standards of medical care in diabetes - 2008 [position statement]. Diabetes Care. 2008;31:S12-S54.
8. Ross SA, Gulve EA, Wang M. Chemistry and biochemistry of type 2 diabetes. Chem Rev. 2004;104:1255-1282.
9. Genuth S. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract. 2006;12(suppl 1):34-41.
10. Massi-Benedetti M. Changing targets in the treatment of type 2 diabetes. Curr Med Res Opin. 2006;22(suppl 2):S5-S13.
11. Wasserman DH, Zinman B. Exercise in individuals with IDDM. Diabetes Care. 1994;17:924-937.
12. Boule NG, Haddad E, Kenny GP, et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. J Am Med Assoc. 2001;286:1218-1227.
13. Sigal RJ, Kenny GP, Wasserman DH, et al. Physical activity/exercise and type 2 diabetes. Diabetes Care. 2004;27:2518-2539.
14. Wallberg-Henriksson H, Wahren J. Effects of nutrition and diabetes mellitus on the regulation of metabolic fuels during exercise. Am J Clin Nutr. 1989;49:938-943.
15. Sinacore DR, Gulve EA. The role of skeletal muscle in glucose transport, glucose homeostasis, and insulin resistance: implications for physical therapy. Phys Ther. 1993;73:878-891.
16. Wahren J, Felig P, Ahlborg G, et al. Glucose metabolism during leg exercise in man. J Clin Invest. 1971;50:2715-2725.
17. Camacho RC, Galassetti P, Davis SN, et al. Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exerc Sport Sci Rev. 2005;33:17-23.
18. Wasserman DH, Williams PE, Lacy DB, et al. Exercise-induced fall in insulin and hepatic carbohydrate metabolism during muscular work. Am J Physiol. 1989;256:E500-E589.
19. Coker RH, Koyama Y, Lacy DB, et al. Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics. Am J Physiol. 1999;277:E1122-E1129.
20. Coker RH, Koyama Y, Denny JC, et al. Prevention of overt hypoglycemia during exercise: stimulation of endogenous glucose production independent of hepatic catecholamine action and changes in pancreatic hormone concentration. Diabetes. 2002;51:1310-1318.
21. Camacho RC, Pencek RR, Lacy DB, et al. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin. Diabetes. 2004;53:285-293.
22. Martin IK, Katz A, Wahren J. Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol. 1995;269:E583-E590.
23. Larsen JJS, Dela F, Kjaer M, et al. The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia. 1997;40:447-453.
24. Wallberg-Henriksson H, Holloszy JO. Contractile activity increases glucose uptake by muscle in severely diabetic rats. J Appl Physiol. 1984;57:1045-1049.
25. Ploug T, Galbo H, Richter EA. Increased muscle glucose uptake during contractions: no need for insulin. Am J Physiol. 1984;247:E726-E731.
26. Nesher R, Karl IE, Kipnis DM. Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am J Physiol 1985;249:C226-C232.
27. Wallberg-Henriksson H, Holloszy JO. Activation of glucose transport in diabetic muscle: responses to contraction and insulin. Am J Physiol. 1985;249:C233-C237.
28. Riddle MC, McDaniel PA, Tive LA. Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM. Diabetes Care. 1997;20:992-994.
29. Larsen JJ, Dela F, Madsbad S, et al. Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care. 1999;22:1647-1654.
30. Lawrence RD. The effect of exercise on insulin action in diabetics. Br Med J. 1926;1:648-650.
31. Neslon JD, Poussier P, Marliss EB, et al. Metabolic response of normal man and insulin-infused diabetics to postprandial exercise. Am J Physiol. 1982;242:E309-E316.
32. Schiffrin A, Parikh S, Marliss EB, et al. Metabolic response to fasting exercise in adolescent insulin-dependent diabetic subjects treated with continuous subcutaneous insulin infusion and intensive conventional therapy. Diabetes Care. 1984;7:255-260.
33. Diabetes Research in Children Network (DirecNet) Study Group. The effects of aerobic exercise on glucose and counter-regulatory hormone concentrations in children with type 1 diabetes. Diabetes Care. 2006;29:20-25.
34. Ertl AC, Davis SN. Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. Diab Metab Res Rev. 2004;20:124-130.
35. Sandoval DA, Davis SN. Metabolic consequences of exercise-associated autonomic failure. Exerc Sport Sci Rev. 2006;34:72-76.
36. Diabetes Research in Children Network (DirecNet) Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr. 2005;147:528-534.
37. Chipkin SR, Klugh SA, Chasan-Taber L. Exercise and diabetes. Cardiol Clin. 2001;19:489-505.
38. Berger M. Adjustment of insulin and oral agent therapy. In: Ruderman N, Devlin JT, Schneider SH, et al., eds. Handbook of Exercise in Diabetes. 2nd ed. Alexandria, VA: American Diabetes Association; 2002:365-376.
39. Flood L, Constance A. Diabetes and exercise safety. Am J Nurs. 2002;102:47-55.
40. Steppel JH, Horton ES. Exercise in the management of type 1 diabetes mellitus. Rev Enaocr Metab Disord. 2003;4:355-360.
41. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88:1322-1335.
42. LeMaster JW, Mueller MJ, Reiber GE, et al. Effect of weight-bearing activity on foot ulcer incidence in people with diabetic peripheral neuropathy: Feet First randomized controlled trial. Phys Ther. 2008;88:1385-1398.
43. Admon G, Weinstein Y, Falk B, et al. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. Pediatrics. 2005;116:e348-e355.
44. Tuominen JA, Karonen SL, Melamies L, et al. Exercise-induced hypoglycemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia. 1995;38:106-111.
45. Rabasa-Lhoret R, Bourque J, Ducros F, et al. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (UltralenteLispro). Diabetes Care. 2001;24:625-630.
46. Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Glucose response to intense aerobic exercise in type 1 diabetes. Diabetes Care. 2003;26:1316-1317.
47. Diabetes Research in Children Network (DirecNet) Study Group. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care. 2006;29:2200-2204.
48. Francescato MP, Geat M, Fusi S, et al. Carbohydrate requirement and insulin concentration during moderate exercise in type 1 diabetic patients. Metabolism. 2004;53:1126-1130.
49. Dubé MC, Weisnagel SJ, Prud'homme D, Lavoie C. Exercise and newer insulins: how much glucose supplement to avoid hypoglycemia? Med Sci Sports Exerc. 2005;37:1276-1282.
50. Soo K, Furler SM, Samaras K, et al. Glycemic responses to exercise in IDDM after simple and complex carbohydrate supplementation. Diabetes Care. 1996;19:575-579.
51. Grimm JJ, Ybarra J, Berne C, et al. A new table for prevention of hypoglycaemia during physical activity in type 1 diabetic patients. Diabetes Metab. 2004;30:465-470.
52. Braatvedt GD, Mildenhall L, Patten C, et al. Insulin requirements and metabolic control in children with diabetes mellitus attending a summer camp. Diabetes Med. 1996;14:258-261.
53. Tuomi T, Honkanen EH, Isomaa B, et al. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. Diabetes Care. 2006;29:189-194.
54. McDonnell ME. Combination therapy with new targets in type 2 diabetes. J Cardiopulm Rehabil Prev. 2007;27:193-201.
55. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1696-1705.
56. Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes. 2002;51(suppl 1):S271-S283.
57. Rizza RA, Cryer PE, Haymond MW, et al. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest. 1980;65:682-689.
58. Clutter WE, Bier DM, Shah SD, et al. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest. 1980;66:94-101.
59. Kjaer M, Engfred K, Fernandes A, et al. Regulation of hepatic glucose production during exercise in humans: role of sympathoadrenergic activity. Am J Physiol. 1993;265:E275-E283.
60. Howlett K, Febbraio M, Hargreaves M. Glucose production during strenuous exercise in humans: role of epinephrine. Am J Physiol. 1999;276:EH30-E1135.
61. Kreisman SH, Halter JB, Vranic M, Marliss EB. Combined infusion of epinephrine and norepinephrine during moderate exercise reproduces the glucoregulatory response of intense exercise. Diabetes. 2003;52:1347-1354.
62. Kjaer M, Keiding S, Engfred K, et al. Glucose homeostasis during exercise in humans with a liver or kidney transplant. Am J Physiol. 1995;268:E636-E644.
63. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest. 1980;65:717-721.
64. Jansson E, Hjemdahl P, Kaijser L. Epinephrine induced changes in muscle carbohydrate metabolism during exercise in male subjects. J Appl Physiol. 1986;60:1466-1470.
65. Purdon C, Brousson M, Nyveen SL, et al. The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects. J Clin Endocrinol Metab. 1993;76:566-573.
66. Richter EA, Kiens B, Saltin B, et al. Skeletal muscle glucose uptake during dynamic exercise in humans: role of muscle mass. Am J Physiol. 1988;254:E555-E561.
67. Kjaer M, Kiens B, Hargreaves M, et al. Influence of active muscle mass on glucose homeostasis during exercise in humans. J Appl Physiol. 1991;71:552-557.
68. Manzon A, Fisher SJ, Morais JA, et al. Glucose infusion partially attenuates glucose production and increases uptake during intense exercise. J Appl Physiol. 1998;85:511-524.
69. Kreisman SH, Manzon A, Nessim SJ, et al. Glucoregulatory responses to intense exercise performed in the postprandial state. Am J Physiol. 2000;278:E786-E793.
70. Kjaer M, Hollenbeck CB, Frey-Hewitt B, etal. Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes. J Appl Physiol. 1990;68:2067-2074.
71. Harmer AR, Chisholm DJ, McKenna MJ, et al. High-intensity training improves plasma glucose and acid-base regulation during intermittent maximal exercise in type 1 diabetes. Diabetes Care. 2007;30:1269-1271.
72. Hartley LH, Mason JW, Hogan RP, et al. Multiple hormonal responses to prolonged exercise in relation to physical mming. J Appl Physiol. 1972;33:607-610.
73. Winder WW, Hickson RC, Hagberg JM, et al. Training-induced changes in hormonal and metabolic responses to submaximal exercise. J Appl Physiol. 1979;46:766-771.
74. Guelfi KJ, Jones TW, Fournier PA. The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care. 2005;28:1289-1294.
75. Guelfi KJ, Jones TW, Fournier PA. Intermittent high-intensity exercise does not increase the risk of early postexercise hypoglycemia in individuals with type 1 diabetes. Diabetes Care. 2005;28:416-418.
76. Guelfi KJ, Ratnam N, Smythe GA, et al. Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes. Am J Physiol. 2007;292:E865-E870.
77. Bussau VA, Ferreira LD, Jones TW, et al. The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes. Diabetes Care. 2006;29:601-606.
78. Willey KA, Fiatarone Singh MA. Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights. Diabetes Care. 2003;26:1580-1588.
79. Braith RW, Stewart KJ. Resistance exercise training: its role in the prevention of cardiovascular disease. Circulation. 2006;113:2642-2650.
80. Eves ND, Plotnikoff RC. Resistance training and type 2 diabetes: considerations for implementation at the population level. Diabetes Care. 2006;29:1933-1941.
81. Dunstan DW, Daly RM, Owen N, et al. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care. 2002;25:1729-1736.
82. Castaneda C, Layne JE, Munoz-Orians L, et al. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care. 2002;25:2335-2341.
83. Holten MK, Zacho M, Gaster M, et al. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes. 2004;53:294-305.
84. Maiorana A, O'Driscoll G, Goodman C, et al. Combined aerobic and resistance exercise improves glycemic control and fitness in type 2 diabetes. Diabetes Res Clin Pract. 2002;56:115-123.
85. Balducci S, Leonetti F, DiMario U, Fallucca F. Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients? Diabetes Care. 2004;27:841-842.
86. Mosher PE, Nash MS, Perry AC, et al. Aerobic circuit exercise training: effect on adolescents with well-controlled insulin-dependent diabetes mellitus. Arch Phys Med Rehabil. 1998;79:652-657.
87. Sigal RJ, Kenny GP, Boule NG, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes. Ann Intern Med. 2007;147:357-369.
88. Marcus RL, Smith S, Morrell G, et al. Comparison of combined aerobic and high-force eccentric resistance exercise with aerobic exercise only for people with tvpe 2 diabetes mellitus. Phys Ther 2008;88:1345-1354.
89. Albright A, Franz M, Hornsby G, et al. American College of Sports Medicine position stand: exercise and type 2 diabetes. Med Sci Sports Exerc. 2000;32:1345-1360.